142 related articles for article (PubMed ID: 27097822)
1. Synergistic Effect of Human Serum Albumin and Fullerene on Gd-DO3A for Tumor-Targeting Imaging.
Zhang Y; Zou T; Guan M; Zhen M; Chen D; Guan X; Han H; Wang C; Shu C
ACS Appl Mater Interfaces; 2016 May; 8(18):11246-54. PubMed ID: 27097822
[TBL] [Abstract][Full Text] [Related]
2. Maximizing the relaxivity of Gd-complex by synergistic effect of HSA and carboxylfullerene.
Zhen M; Zheng J; Ye L; Li S; Jin C; Li K; Qiu D; Han H; Shu C; Yang Y; Wang C
ACS Appl Mater Interfaces; 2012 Jul; 4(7):3724-9. PubMed ID: 22704586
[TBL] [Abstract][Full Text] [Related]
3. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
Yang CT; Chandrasekharan P; He T; Poh Z; Raju A; Chuang KH; Robins EG
Biomaterials; 2014 Jan; 35(1):327-36. PubMed ID: 24138829
[TBL] [Abstract][Full Text] [Related]
4. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.
Giesel FL; von Tengg-Kobligk H; Wilkinson ID; Siegler P; von der Lieth CW; Frank M; Lodemann KP; Essig M
Invest Radiol; 2006 Mar; 41(3):222-8. PubMed ID: 16481904
[TBL] [Abstract][Full Text] [Related]
5. In Vivo evaluation of a PAMAM-cystamine-(Gd-DO3A) conjugate as a biodegradable macromolecular MRI contrast agent.
Xu R; Wang Y; Wang X; Jeong EK; Parker DL; Lu ZR
Exp Biol Med (Maywood); 2007 Sep; 232(8):1081-9. PubMed ID: 17720954
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
Chandrasekharan P; Yong CX; Poh Z; He T; He Z; Liu S; Robins EG; Chuang KH; Yang CT
Biomaterials; 2012 Dec; 33(36):9225-31. PubMed ID: 23026708
[TBL] [Abstract][Full Text] [Related]
7. Macrocyclic paramagnetic agents for MRI: Determinants of relaxivity and strategies for their improvement.
Fringuello Mingo A; Colombo Serra S; Baroni S; Cabella C; Napolitano R; Hawala I; Carnovale IM; Lattuada L; Tedoldi F; Aime S
Magn Reson Med; 2017 Oct; 78(4):1523-1532. PubMed ID: 27791281
[TBL] [Abstract][Full Text] [Related]
8. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging.
Mishra A; Pfeuffer J; Mishra R; Engelmann J; Mishra AK; Ugurbil K; Logothetis NK
Bioconjug Chem; 2006; 17(3):773-80. PubMed ID: 16704217
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable cystamine spacer facilitates the clearance of Gd(III) chelates in poly(glutamic acid) Gd-DO3A conjugates for contrast-enhanced MR imaging.
Ke T; Feng Y; Guo J; Parker DL; Lu ZR
Magn Reson Imaging; 2006 Sep; 24(7):931-40. PubMed ID: 16916710
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, conjugation and relaxation studies of gadolinium(III)-4-benzothiazol-2-yl-phenylamine as a potential brain specific MR contrast agent.
Saini N; Varshney R; Tiwari AK; Kaul A; Allard M; Ishar MP; Mishra AK
Dalton Trans; 2013 Apr; 42(14):4994-5003. PubMed ID: 23389482
[TBL] [Abstract][Full Text] [Related]
11. Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.
Watcharin W; Schmithals C; Pleli T; Köberle V; Korkusuz H; Hübner F; Waidmann O; Zeuzem S; Korf HW; Terfort A; Gelperina S; Vogl TJ; Kreuter J; Piiper A
J Control Release; 2015 Feb; 199():63-71. PubMed ID: 25499552
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of HE-24.8: a polymeric contrast agent for magnetic resonance angiography.
Kiessling F; Heilmann M; Lammers T; Ulbrich K; Subr V; Peschke P; Waengler B; Mier W; Schrenk HH; Bock M; Schad L; Semmler W
Bioconjug Chem; 2006; 17(1):42-51. PubMed ID: 16417250
[TBL] [Abstract][Full Text] [Related]
13. Contrast enhancement of the brain by folate-conjugated gadolinium-diethylenetriaminepentaacetic acid-human serum albumin nanoparticles by magnetic resonance imaging.
Korkusuz H; Ulbrich K; Bihrer V; Welzel K; Chernikov V; Knobloch T; Petersen S; Huebner F; Ackermann H; Gelperina S; Korkusuz Y; Kromen W; Hammerstingl R; Haupenthal J; Fiehler J; Zeuzem S; Kreuter J; Vogl TJ; Piiper A
Mol Imaging; 2012; 11(4):272-9. PubMed ID: 22954143
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of a new bioactivated paramagnetic gadolinium(III) complex [Gd(DOTA-FPG)(H2O)] for tracing gene expression.
Chang YT; Cheng CM; Su YZ; Lee WT; Hsu JS; Liu GC; Cheng TL; Wang YM
Bioconjug Chem; 2007; 18(6):1716-27. PubMed ID: 17935289
[TBL] [Abstract][Full Text] [Related]
15. Improving the MR Imaging Sensitivity of Upconversion Nanoparticles by an Internal and External Incorporation of the Gd(3+) Strategy for in Vivo Tumor-Targeted Imaging.
Du H; Yu J; Guo D; Yang W; Wang J; Zhang B
Langmuir; 2016 Feb; 32(4):1155-65. PubMed ID: 26740341
[TBL] [Abstract][Full Text] [Related]
16. Structure-relaxivity relationships of serum albumin targeted MRI probes based on a single amino acid Gd complex.
Boros E; Caravan P
J Med Chem; 2013 Feb; 56(4):1782-6. PubMed ID: 23391162
[TBL] [Abstract][Full Text] [Related]
17. Serum albumin targeted, pH-dependent magnetic resonance relaxation agents.
Moriggi L; Yaseen MA; Helm L; Caravan P
Chemistry; 2012 Mar; 18(12):3675-86. PubMed ID: 22328098
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and physicochemical characterization of two gadolinium(III) TTDA-like complexes and their interaction with human serum albumin.
Ou MH; Tu CH; Tsai SC; Lee WT; Liu GC; Wang YM
Inorg Chem; 2006 Jan; 45(1):244-54. PubMed ID: 16390062
[TBL] [Abstract][Full Text] [Related]
19. In vivo labeling of B16 melanoma tumor xenograft with a thiol-reactive gadolinium based MRI contrast agent.
Menchise V; Digilio G; Gianolio E; Cittadino E; Catanzaro V; Carrera C; Aime S
Mol Pharm; 2011 Oct; 8(5):1750-6. PubMed ID: 21780833
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity.
Parac-Vogt TN; Kimpe K; Laurent S; Vander Elst L; Burtea C; Chen F; Muller RN; Ni Y; Verbruggen A; Binnemans K
Chemistry; 2005 May; 11(10):3077-86. PubMed ID: 15776492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
